KENNEDY CAPITAL MANAGEMENT LLC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 66 filers reported holding APREA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$623,000
-35.5%
334,796
-0.6%
0.02%
-25.0%
Q4 2021$966,000
-44.8%
336,730
-1.7%
0.02%
-48.7%
Q3 2021$1,750,000
+1.3%
342,486
-3.2%
0.04%
+5.4%
Q2 2021$1,727,000
+546.8%
353,926
+575.2%
0.04%
+640.0%
Q1 2021$267,000
-94.1%
52,415
-72.0%
0.01%
-96.1%
Q3 2020$4,508,000
-11.5%
187,355
+42.6%
0.13%
-12.2%
Q2 2020$5,096,000
+15.2%
131,414
+3.3%
0.15%
-9.8%
Q1 2020$4,423,000
+3.7%
127,230
+36.8%
0.16%
+56.7%
Q4 2019$4,267,00092,9890.10%
Other shareholders
APREA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
5AM Venture Management, LLC 1,377,654$6,778,0002.28%
Versant Venture Management, LLC 1,426,328$7,018,0000.73%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$206,0000.38%
Redmile Group, LLC 1,268,718$6,242,0000.08%
Gyon Technologies Capital Management, LP 41,801$206,0000.07%
SECTORAL ASSET MANAGEMENT INC 163,681$805,0000.06%
Palo Alto Investors LP 128,770$634,0000.03%
Walleye Capital LLC 100,800$496,0000.03%
Virtus ETF Advisers LLC 10,261$50,0000.02%
Candriam S.C.A. 362,346$1,783,0000.01%
View complete list of APREA THERAPEUTICS INC shareholders